Homocysteine levels in polycystic ovary syndrome (PCOS) patients
Not Applicable
Completed
- Conditions
- Improving the metabolic competence in oocytes of PCOS patients undergoing IVF treatment.Pregnancy and Childbirth
- Registration Number
- ISRCTN55983518
- Lead Sponsor
- Acibadem Healthcare
- Brief Summary
2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37300649/ (added 12/06/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 43
Inclusion Criteria
1. PCOS patients diagnosed using Rotterdam's Criteria
2. Primary infertility for at least 1 year
3. No other condition leading to infertility
Exclusion Criteria
Patients who requested two embryos but implanted only one.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy, calculated as number of fetuses with heart activity beyond 20 weeks of gestation per transferred embryo
- Secondary Outcome Measures
Name Time Method 1. FSH consumption during stimulation, calculated as cumulative number if FSH units injected <br>2. Fertilization rate, calculated as the rate of fertilized oocytes (2 PN) out of the total number of inseminated oocytes <br>3. Blastocyst rate, calculated as the rate of fertilized oocytes reaching the blastocyst stage at 5-6 days <br>4. Biochemical pregnancy, calculated as the rate of positive hCG at 7 days post embryo transfer out of the number of patients receiving an embryo transfer